US Stock MarketDetailed Quotes

TOVX Theriva Biologics

Watchlist
  • 1.5050
  • -0.0750-4.75%
Trading Dec 27 12:24 ET
4.19MMarket Cap-0.05P/E (TTM)

Theriva Biologics Key Stats

Theriva Biologics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q323.180K / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
Mar 25, 20242023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q323.180K / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
Mar 25, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Theriva Biologics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Nov 13, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data